Abstract:Highlights • We propose a novel drug repurposing approach, which integrates gene expression profile and gene regulatory network to compute inhibition score using the shortest distance in the tissue-specific network, called DRIE. • Experimental results on multiple datasets indicate that DRIE outperforms state-of-the-art methods for cancer drug repurposing prediction. • Case studies show that our method can effectively discover novel drug-disease associations. Numerous computational drug repurposing methods have emerged as efficient alternatives to costly and time-consuming traditional drug discovery approaches. Some of these methods are based on the assumption that the candidate drug should have a reversal effect on disease-associated genes. However, such methods are not applicable in the case that there is limited overlap between disease-related genes and drug-perturbed genes. In this study, we proposed a novel D rug R epurposing method based on the I nhibition E ffect on gene regulatory network ( DRIE ) to identify potential drugs for cancer treatment. DRIE integrated gene expression profile and gene regulatory network to calculate inhibition score by using the shortest path in the disease-specific network. The results on eleven datasets indicated the superior performance of DRIE when compared to other state-of-the-art methods. Case studies showed that our method effectively discovered novel drug-disease associations. Our findings demonstrated that the top-ranked drug candidates had been already validated by CTD database. Additionally, it clearly identified potential agents for three cancers (colorectal, breast, and lung cancer), which was beneficial when annotating drug-disease relationships in the CTD. This study proposed a novel framework for drug repurposing, which would be helpful for drug discovery and development. Availability and implementation The source code of our method is freely available at https://github.com/eshinesimida/DRIE. Graphical abstract Download : Download high-res image (178KB) Download : Download full-size image

Drug Repurposing Based on Drug-Drug Interaction

SRP: A Concise Non-Parametric Similarity-Rank-based Model for Predicting Drug-Target Interactions

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Predicting Drug-Target Interactions Between New Drugs and New Targets via Pairwise K-nearest Neighbor and Automatic Similarity Selection.

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

A drug repurposing method based on inhibition effect on gene regulatory network

Similarity-Based Integrated Method For Predicting Drug-Disease Interactions

Measuring drug similarity using drug–drug interactions

Drug–Target Interaction Prediction Based on an Interactive Inference Network

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

Network-Based Methods for Prediction of Drug-Target Interactions

Clinical connectivity map for drug repurposing: using laboratory tests to bridge drugs and diseases

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

A Pathway Profile-Based Method for Drug Repositioning

Integrated edge information and pathway topology for drug-disease associations

DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing

Link Prediction Only with Interaction Data and Its Application on Drug Repositioning

Prediction of Drug-Target Interactions and Drug Repositioning Via Network-Based Inference